Human anti-IL-23 antibodies, compositions, methods and uses

Details for Australian Patent Application No. 2006330411 (hide)

Owner Janssen Biotech, Inc.

Inventors Sweet, Raymond; Carton, Jill; Orlovsky, Yevgeniya I.; Benson, Jacqueline; Rauchenberger, Robert; Cunningham, Mark

Agent Shelston IP

Pub. Number AU-B-2006330411

PCT Pub. Number WO2007/076524

Priority 60/754,889 29.12.05 US

Filing date 28 December 2006

Wipo publication date 5 July 2007

Acceptance publication date 12 July 2012

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/567 Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/076524 Priority application(s): WO2007/076524

12 July 2012 Application Accepted

  Published as AU-B-2006330411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330418-Compositions and methods for preventing or treating inflammatory bowel disease

2006330410-Markers and methods for assessing and treating psoriasis and related disorders